| |
|
|
|
Harvard Bioscience  
|
|
2.82 0.06 (0.02%) |
06-05 12:41 |
|
Open: |
2.8 |
Pre close: |
2.76 |
Target:
|
3.39
|
|
High: |
2.82 |
Low: |
2.79 |
Resistance:
|
2.90
3.39
|
|
Volume: |
63,114 |
Market Cap: |
108M |
Support:
|
2.39
2.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.72
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
2.69 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
2.63  |
Stochastic Oscillator |
%K(14,3):
|
85.40 |
|
MA(250): |
2.64 |
%D(3): |
65.38 |
|
Average Volume(K) |
3-Month: |
18450
|
52-Week |
High:
|
3.50 |
|
10-Days: |
9875 |
Low: |
1.39 |
|
RSI |
RSI(14):
|
59.86 |
Change(%): |
39.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.181 |
Return on Equity (ttm) |
-8.7 |
Shares Out. (M) |
38.38 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-0.4 |
Shares Float (M) |
30.95 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.80 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
-15.7 |
% Held by Institutions |
67.77 |
|
Forward EPS |
-0.080 |
Gross Profit (p.s.) |
1.682 |
Shares Short (K) |
1100 |
|
Book Value (p.s.) |
1.980 |
EBITDA (p.s.) |
0.172 |
P/E |
-15.52 |
|
Sales Per Share |
2.912 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.42 |
|
Profit Margin |
-6.11 |
Operating Cash Flow
(M) |
8.91 |
P/S |
0.96 |
|
Operating Margin |
-0.97 |
Levered Free Cash Flow
(M) |
11.02 |
P/CF |
12.10 |
|
|
|
|
|
|
